PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11778746

Introduction to endoscopic mucosal resection.

K Matsuda
View original source ↗Export metadata ↓

Abstract

The advent of videoendoscopes showed the very minute details of the gastrointestinal tract. Three American and five Japanese endoscopists who are experts and founders in their original EMR for the entire gastrointestinal tract were invited. All of them have tremendous experience with EMR. One can appreciate the technique and pitfalls of EMR through their data analyses based on a large number of cases. In western countries, early esophageal cancers arising from Barrett's esophagus seem to be the most likely candidates for EMR. It is hoped that these techniques aid the reader's endoscopic practice and provide a better quality of life to patients.

Explore related subjects

Digestive System NeoplasmsEndoscopy, Digestive SystemHumansJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Matsuda. 2001. Introduction to endoscopic mucosal resection.. https://pubmed.ncbi.nlm.nih.gov/11778746/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

[Gastrojejunostomy versus endoscopic stent placement as palliative treatment for a malignant constriction of the duodenum: the SUSTENT-study].

Gastric-outlet obstruction often results from inoperable distal stomach, periampullary (pancreatic or cholangio-), or duodenal carcinoma. Gastrojejunostomy and stent placement are standard palliative treatments. An advantage of gastrojejunostomy is the long-term efficacy; a disadvantage is the prolonged postoperative recovery time. The advantage of stent placement is the rapid ability to consume a soft diet; a disadvantage is that around 20% of the patients require re-intervention because of recurrent symptoms. A randomised multicentre study was started in January 2006 in the Netherlands in which gastrojejunostomy is compared with stent placement in the palliative treatment of malignant gastroduodenal obstruction: 'Surgery versus stent for malignant gastroduodenal obstruction', the SUSTENT-study. The primary-outcome measurement is survival adjusted for the time patients are not able to consume (soft) food. Other outcome measurements are medical effects (complications, re-interventions), quality of life, cost and cost-effectiveness. This study aims to provide individualised recommendations for effective palliative treatment of patients with malignant gastroduodenal obstruction.

Digestive System Neoplasms↗